Presentation Abstract: Exploring the Potential for CKM-Oriented Drug Discovery Through the Evaluation of GLP-1 Receptor Agonists in SDT Fatty Rats

Abstract No.: WCN26-AB-5615
Presentation Date: March 30, 2026 (Monday)
Poster Board No.: P121
Venue: Exhibition Hall B (1F)
Session Time: 17:00–18:00

Key Word：
Cardiovascular–Kidney–Metabolic, Semaglutide, GLP-1 receptor agonist, SDT fatty rat

François Briand^１、Guillaume Bourdier^２、Estelle Grasset^１、Rana Assaly^２Caroline Dubroca^２、Masami Shinohara^３、Thierry Sulpice^１、２ 

^１Physiogenex, 280 rue de l’Hers, 31750, Escalquens, France
^２Cardiomedex, 280 rue de l’Hers, 31750, Escalquens, France
^３CLEA Japan, Inc., 1–2–7 Higashiyama, Meguro-ku, Tokyo 153-8533, Japan

For more details, please click here (Google Search)

• World Congress of Nephrology 2026
• Monday, March 30, 2026 | 17:00–18:00 Pacifico Yokohama, Japan

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

: https://www.clea-japan.com/en/products/diabetes/item_a0150

 

Inquiry

If you have any questions, please feel free to contact us.